The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The company is the Clinical Research Organisation of Caplin Point Laboratories
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The approval allows it to market its products in the country
Sumatriptan Injection USP is indicated in adults for acute treatment of migraine with or without aura, and acute treatment of cluster headache
Subscribe To Our Newsletter & Stay Updated
